VivoSim Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
VivoSim Labs, Inc. (VIVS) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 0 shares for the 9-month period ending 2014-12-31, per its 10-Q filed 2015-02-06.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2015-02-06
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2014-12-31 was 0.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2014-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2013-12-31 was 0.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2013-09-30 was 0.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2014 was 60.00K shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2012 was 1.38M shares, a 2147.34% increase from fiscal 2011.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2011 was 61.41K shares, a 72.01% decline from fiscal 2010.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2010 was 219.37K shares, a 68.20% increase from fiscal 2009.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 48 month |
|---|---|---|---|---|---|
| 2014-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-06 | 0.00 shares 10-Q · filed 2015-02-06 | |||
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-07 | ||||
| 2014-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10 | 0.00 shares derived: sum of 2 quarters · filed 2014-06-10 | 0.00 shares derived: sum of 3 quarters · filed 2014-06-10 | 60.00K shares 10-K · filed 2014-06-10 | |
| 2013-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06 | 0.00 shares derived: sum of 2 quarters · filed 2014-02-06 | 60.00K shares 10-Q · filed 2014-02-06 | 115.00K shares derived: sum of 4 quarters · filed 2014-06-10 | |
| 2013-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-08 | 60.00K shares 10-Q · filed 2013-11-08 | 115.00K shares derived: sum of 3 quarters · filed 2014-06-10 | 115.00K shares derived: sum of 4 quarters · filed 2014-06-10 | |
| 2013-06-30 | 60.00K shares 10-Q · filed 2013-08-09 | 115.00K shares derived: sum of 2 quarters · filed 2014-06-10 | 115.00K shares derived: sum of 3 quarters · filed 2014-06-10 | ||
| 2013-03-31 | 55.00K shares 10-K · filed 2014-06-10 | 55.00K shares derived: sum of 2 quarters · filed 2014-06-10 | |||
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10 | 1.38M shares 10-K · filed 2014-06-10 | |||
| 2012-09-30 | 1.38M shares 10-Q · filed 2012-11-14 | ||||
| 2011-12-31 | 61.41K shares 10-K · filed 2014-06-10 | 1.38M shares 10-Q · filed 2012-11-14 | |||
| 2010-12-31 | 219.37K shares 10-K · filed 2014-06-10 | ||||
| 2009-12-31 | 130.42K shares 10-K · filed 2014-06-10 | ||||
| 2008-12-31 | 12.63M shares 10-K · filed 2014-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |